These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 16490861)

  • 1. Vesicular eczema after intravenous immunoglobulin therapy for treatment of Stevens-Johnson syndrome.
    Young PK; Ruggeri SY; Galbraith S; Drolet BA
    Arch Dermatol; 2006 Feb; 142(2):247-8. PubMed ID: 16490861
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous immunoglobulin-induced, non-eczematous, vesiculobullous eruptions in Stevens-Johnson syndrome.
    Lin WL; Lin WC; Chang YC; Yang LC; Hung SI; Hong HS; Chung WH
    Am J Clin Dermatol; 2009; 10(5):339-42. PubMed ID: 19658448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe dyshidrotic eczema after intravenous immunoglobulin therapy for Kawasaki syndrome.
    Shiraishi T; Yamamoto T
    Pediatr Dermatol; 2013; 30(3):e30-1. PubMed ID: 22304420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin in the treatment of childhood Stevens Johnson syndrome.
    Britton P; Deng L
    J Paediatr Child Health; 2011 Jun; 47(6):392-5. PubMed ID: 21649751
    [No Abstract]   [Full Text] [Related]  

  • 5. [Is intravenous immunoglobulin effective in toxic epidermal necrolysis and Stevens-Johnson syndrome?].
    Navajas L; Rada G
    Medwave; 2014 Oct; 14(9):e6024. PubMed ID: 25340656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin therapy for Stevens-Johnson syndrome.
    Brett AS; Philips D; Lynn AW
    South Med J; 2001 Mar; 94(3):342-3. PubMed ID: 11284525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
    Yang Y; Xu J; Li F; Zhu X
    Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyshidrotic eczema associated with the use of IVIg.
    Kotan D; Erdem T; Acar BA; Boluk A
    BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23417935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin prophylaxis for recurrent Stevens-Johnson syndrome.
    Hebert AA; Bogle MA
    J Am Acad Dermatol; 2004 Feb; 50(2):286-8. PubMed ID: 14726889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyshidrotic-like spongiotic dermatitis after intravenous immunoglobulin therapy.
    Uyttendaele H; Obadiah J; Grossman M
    J Drugs Dermatol; 2003 Jun; 2(3):337-41. PubMed ID: 12848120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pompholyx (vesicular eczema) after i.v. immunoglobulin therapy for neurologic disease.
    Iannaccone S; Sferrazza B; Quattrini A; Smirne S; Ferini-Strambi L
    Neurology; 1999 Sep; 53(5):1154-5. PubMed ID: 10496291
    [No Abstract]   [Full Text] [Related]  

  • 12. Pompholyx induced by intravenous immunoglobulin therapy.
    Llombart M; García-Abujeta JL; Sánchez-Pérez RM; Hernando de Larramendi C
    J Investig Allergol Clin Immunol; 2007; 17(4):277-8. PubMed ID: 17694704
    [No Abstract]   [Full Text] [Related]  

  • 13. Impairment of renal function after intravenous immunoglobulin.
    Soares SM; Sethi S
    Nephrol Dial Transplant; 2006 Mar; 21(3):816-7. PubMed ID: 16399766
    [No Abstract]   [Full Text] [Related]  

  • 14. Toxic epidermal necrolysis treatment and outcomes: a retrospective analysis of 10 patients treated with intravenous immunoglobulin.
    Mehregan D; Van Vreede A; Goralewski M
    Int J Dermatol; 2016 Jun; 55(6):e356-60. PubMed ID: 26694974
    [No Abstract]   [Full Text] [Related]  

  • 15. Practical guidelines for the management of toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Fromowitz JS; Ramos-Caro FA; Flowers FP;
    Int J Dermatol; 2007 Oct; 46(10):1092-4. PubMed ID: 17910723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe eczematous skin reaction after high-dose intravenous immunoglobulin infusion: report of 4 cases and review of the literature.
    Vecchietti G; Kerl K; Prins C; Kaya G; Saurat JH; French LE
    Arch Dermatol; 2006 Feb; 142(2):213-7. PubMed ID: 16490849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research in Stevens-Johnson syndrome/toxic epidermal necrolysis (TEN): a network of specialist TEN centres is needed to undertake effective clinical studies and therapeutic trials.
    Creamer D; Walsh S
    Br J Dermatol; 2013 Dec; 169(6):1177. PubMed ID: 24299527
    [No Abstract]   [Full Text] [Related]  

  • 18. Pompholyx of the hands after intravenous immunoglobulin therapy for clinically isolated syndrome: a paediatric case.
    Brazzelli V; Grassi S; Savasta S; Ruffinazzi G; Carugno A; Barbaccia V; Marseglia GL; Borroni G
    Int J Immunopathol Pharmacol; 2014; 27(1):127-30. PubMed ID: 24674688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyshidrotic eczema following intravenous immunoglobulin treatment.
    Lee KC; Ladizinski B
    CMAJ; 2013 Aug; 185(11):E530. PubMed ID: 23209117
    [No Abstract]   [Full Text] [Related]  

  • 20. Dyshidrotic eczema and seborrheic dermatitis-like eczematous eruption following intravenous immunoglobulin therapy.
    Takci Z; Guler Simsek G; Uzuner H; Akbayrak A; Yıldız Seckin H; Karadag AS
    Dermatol Ther; 2020 Nov; 33(6):e14147. PubMed ID: 32767429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.